Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 20
Filter
1.
PLoS One ; 14(6): e0217748, 2019.
Article in English | MEDLINE | ID: mdl-31220097

ABSTRACT

BACKGROUND: Thromboprophylaxis for patients with non-surgical isolated lower-limb trauma requiring immobilization is a matter of debate. Our aim was to develop and validate a clinical risk- stratification model based on Trauma, Immobilization and Patients' characteristics (the TIP score). METHODS: The TIP score criteria and the cut-off were selected by a consensus of international experts (n = 27) using the Delphi method. Retrospective validation was performed in a population-based case-control study (MEGA study). The potential score's impact in anticoagulant treatment was assessed in a prospective single-center observational cohort study. FINDINGS: After four successive rounds, 30 items constituting the TIP score were selected: thirteen items for trauma, three for immobilization and 14 for patient characteristics were selected, each rated on a scale of 1 to 3. In the validation database, the TIP score had an AUC of 0·77 (95% CI 0.70 to 0.85). Using the cut-off proposed by the experts (≥5) and assuming a prevalence of 1·8%, the TIP scores had a sensitivity, specificity and negative predictive values of 89·9%, 30·7% and 99·4% respectively. In the prospective cohort, 84·2% (165/196) of all the patients concerned who presented at the emergency department had a low VTE risk not requiring thromboprophylaxis according to their TIP scores. The 3-month rate of symptomatic VTE was 1/196 [95% CI 0.1-2.8] this patient was in the sub-group TIP score ≥5. CONCLUSION: For patients with non-surgical lower-limb trauma and orthopedic immobilization, the TIP score allows an individual VTE risk-assessment and shows promising results in guiding thromboprophylaxis.


Subject(s)
Casts, Surgical/adverse effects , Immobilization/adverse effects , Leg Injuries/complications , Venous Thromboembolism/etiology , Case-Control Studies , Delphi Technique , Humans , Prospective Studies , Reproducibility of Results , Retrospective Studies , Risk Factors , Venous Thromboembolism/prevention & control
2.
Eur J Public Health ; 28(6): 1043-1049, 2018 12 01.
Article in English | MEDLINE | ID: mdl-30395217

ABSTRACT

Background: Schizophrenia is a chronic disease associated with significant and long-lasting effects on health, and it is also a social and financial burden, not only for patients but also for families, other caregivers, and the wider society. It is essential to conduct the assessment of indirect costs, to understand all the effects of the disease on society. Our aim is to gain a better understanding of the indirect costs of schizophrenia in Europe. Methods: We conducted a comprehensive systematic literature review covering EMBASE, Medline, and PsycINFO as well as reviewing Health Technology Assessment databases from different countries. We used a qualitative research synthesis for presenting information, as most of the studies were methodologically diverse, a quantitative analysis would have been impractical. Results: Indirect cost adjusted to inflation ranged vastly between studies included in the review from 119 Euros to 62, 034 Euros annually. The average proportion of indirect costs of total costs was 44%. Studies highlighted important cost drivers as age, gender, and disease severity, explaining the variation in costs between treatment and patient groups. Conclusions: Regardless of the methodological heterogeneity of the reviewed studies, there was an agreement about the significance of indirect costs of schizophrenia on the society. Considering the relatively high prevalence of schizophrenia in Europe, a need for more cost of illness studies especially from Central Eastern and Southern Europe is suggested.


Subject(s)
Cost of Illness , Health Care Costs , Schizophrenia/economics , Adolescent , Adult , Aged , Europe , Female , Humans , Male , Middle Aged , Young Adult
3.
J Thromb Haemost ; 16(11): 2218-2222, 2018 11.
Article in English | MEDLINE | ID: mdl-30160361

ABSTRACT

Essentials The risk of recurrent venous thrombosis (VT) after leg-cast in patients with prior VT is unknown. In a nested case-control study within the MEGA follow-up study we aimed to estimate this risk. Patients with a history of VT who require lower-leg cast have a 4.5-fold risk for recurrence. This relative risk translates to an absolute risk for recurrent VT of about 3.2% within 3 months. SUMMARY: Background Patients with lower-leg cast immobilization have a substantially increased risk of developing a first venous thrombosis (VT), whereas the risk in patients with a history of VT is as yet unknown. Aims To estimate the risk of recurrent VT after lower-leg cast immobilization in patients with a history of VT. Methods A case-control study nested within a cohort of 4597 patients with a first VT who were followed over time for recurrence from 1999 to 2010 (MEGA follow-up study). Participants completed a questionnaire on risk factors for recurrent thrombosis, including having a cast in the first 3 months before a recurrence (cases) or a random 3-month period during follow-up for participants without recurrence (controls). In total, 2723/4597 (59%) participants returned the questionnaire. Odds ratios (ORs), adjusted for age and sex, were calculated to compare risks of recurrence between subjects with and without a cast. Results A total of 2525/2723 participants (93%) filled out information on cast immobilization and were included in the analysis (451 cases; 2074 controls). Twenty (1.0%) controls and 10 (2.2%) cases reported having had a lower-leg cast in the 3 months before the control or recurrence date (adjusted OR, 2.4; 95% confidence Interval [CI], 1.1-5.3). We cross-checked the data with these patients' medical records. Cast application within 3 months was verified in seven (0.3%) controls vs. six (1.3%) cases, leading to an adjusted OR of 4.5 (95% CI, 1.5-14.0) and corresponding cumulative incidence of 3.2%. Conclusions Lower-leg cast immobilization increases the risk of recurrent VT in the 3 months after its application in patients with a history of VT.


Subject(s)
Fractures, Bone/complications , Immobilization/adverse effects , Pulmonary Embolism/complications , Venous Thrombosis/complications , Venous Thrombosis/epidemiology , Achilles Tendon , Adult , Body Mass Index , Case-Control Studies , Female , Follow-Up Studies , Genetic Predisposition to Disease , Humans , Incidence , Male , Middle Aged , Odds Ratio , Recurrence , Risk Factors , Surveys and Questionnaires , Venous Thrombosis/etiology
4.
Value Health ; 17(7): A556, 2014 Nov.
Article in English | MEDLINE | ID: mdl-27201825
5.
Acta Neurol Scand ; 126(2): 109-15, 2012 Aug.
Article in English | MEDLINE | ID: mdl-22050386

ABSTRACT

OBJECTIVES AND METHODS: Genetic predisposition of the inflammatory host response may affect the development of stroke. On the basis of the theory of infectious burden and risk of stroke, we considered it of interest to investigate the relevance of the single-nucleotide polymorphisms (SNPs) in the DEFB1 gene and the copy number variant (CNV) of the DEFB4 genes in ischemic stroke. RESULTS: There were no significant differences in the genotype frequencies of the three SNPs of the DEFB1 gene between the patients with stroke (n = 312) and the healthy blood donors (n = 221). However, a higher frequency of a lower (<4) copy number of the DEFB4 gene was observed in the patients with ischemic stroke as compared with the healthy controls (40% vs 24%, respectively). Additionally, low plasma concentrations of hBD-2 (187 ± 20 pg/ml) were characteristic of the patients with fewer than four copy numbers relative to those with more than four copy numbers (385 ± 35 pg/ml). CONCLUSIONS: The low copy number of the DEFB4 gene, involving a weakened antimicrobial defense of the host, might be important in the pathogenesis of stroke.


Subject(s)
Genetic Predisposition to Disease/genetics , Stroke/genetics , beta-Defensins/genetics , Female , Gene Dosage , Humans , Male , Middle Aged , Polymorphism, Single Nucleotide , Reverse Transcriptase Polymerase Chain Reaction
6.
Eur J Neurosci ; 25(8): 2445-56, 2007 Apr.
Article in English | MEDLINE | ID: mdl-17445240

ABSTRACT

Cannabinoid ligands show therapeutic potential in a variety of disorders including anxiety. However, the anxiety-related effects of cannabinoids remain controversial as agonists show opposite effects in mice and rats. Here we compared the effects of the cannabinoid agonist WIN-55,212 and the CB1 antagonist AM-251 in CD1 mice and Wistar rats. Special attention was paid to antagonist-agonist interactions, which had not yet been studied in rats. In mice, WIN-55,212 decreased whereas AM-251 increased anxiety. The antagonist abolished the effects of the agonist. In contrast, WIN-55,212 increased anxiety in rats. Surprisingly, the antagonist potentiated this effect. Cannabinoids affect both GABAergic and glutamatergic functions, which play opposite roles in anxiety. We hypothesized that discrepant findings resulted from species differences in the relative responsiveness of the two transmitter systems to cannabinoids. We investigated this hypothesis by studying the effects of WIN-55,212 on evoked hippocampal inhibitory and excitatory postsynaptic currents (IPSCs and EPSCs). IPSCs were one order of magnitude more sensitive to WIN-55,212 in mice than in rats. In mice, IPSCs were more sensitive than EPSCs to WIN-55,212. This is the first study showing that the relative cannabinoid sensitivity of GABA and glutamate neurotransmission is species-dependent. Based on behavioural and electrophysiological findings, we hypothesize that WIN-55,212 reduced anxiety in mice by affecting GABA neurotransmission whereas it increased anxiety in rats via glutamatergic mechanisms. In rats, AM-251 potentiated this anxiogenic effect by inhibiting the anxiolytic GABAergic mechanism. We suggest that the anxiety-related effects of cannabinoids depend on the relative cannabinoid responsiveness of GABAergic and glutamatergic neurotransmission.


Subject(s)
Anxiety/drug therapy , Cannabinoids , Glutamic Acid/metabolism , Synaptic Transmission/physiology , gamma-Aminobutyric Acid/metabolism , Analgesics/pharmacology , Analgesics/therapeutic use , Animals , Anti-Anxiety Agents/pharmacology , Anti-Anxiety Agents/therapeutic use , Benzoxazines/pharmacology , Benzoxazines/therapeutic use , Cannabinoids/agonists , Cannabinoids/antagonists & inhibitors , Cannabinoids/pharmacology , Cannabinoids/therapeutic use , Chlordiazepoxide/pharmacology , Chlordiazepoxide/therapeutic use , Excitatory Postsynaptic Potentials/physiology , Exploratory Behavior/drug effects , Hippocampus/cytology , Hippocampus/drug effects , Inhibitory Postsynaptic Potentials/physiology , Ligands , Male , Mice , Morpholines/pharmacology , Morpholines/therapeutic use , Naphthalenes/pharmacology , Naphthalenes/therapeutic use , Patch-Clamp Techniques , Piperidines/pharmacology , Piperidines/therapeutic use , Pyrazoles/pharmacology , Pyrazoles/therapeutic use , Rats , Rats, Wistar , Receptor, Cannabinoid, CB1/metabolism
7.
J Spinal Disord Tech ; 19(4): 295-8, 2006 Jun.
Article in English | MEDLINE | ID: mdl-16778667

ABSTRACT

In this report we discuss the case of a child who was initially diagnosed at 1 month of age with congenital muscular torticollis. After falling off a slide at 22 months of age, the patient had onset of pain and an abrupt worsening of his torticollis. After a full workup, it was found that the patient had a C1 fracture and a disproportionately large ipsilateral occipital "coconut" condyle. We believe this congenital anomaly to be the cause of his original head tilt and also predisposed him to C1 fracture and worsening head tilt.


Subject(s)
Cervical Vertebrae/diagnostic imaging , Cervical Vertebrae/injuries , Occipital Bone/abnormalities , Occipital Bone/diagnostic imaging , Spinal Fractures/diagnostic imaging , Torticollis/diagnostic imaging , Torticollis/etiology , Bone Diseases, Developmental/congenital , Bone Diseases, Developmental/diagnostic imaging , Humans , Infant , Infant, Newborn , Male , Radiography
8.
Pediatr Res ; 47(4 Pt 1): 444-50, 2000 Apr.
Article in English | MEDLINE | ID: mdl-10759149

ABSTRACT

Lactose, the major carbohydrate of human milk, is synthesized in the Golgi from glucose and UDP-galactose. The lactating mammary gland is unique in its requirement for the transport of glucose into Golgi. Glucose transporter-1 (GLUT1) is the only isoform of the glucose transporter family expressed in mammary gland. In most cells, GLUT1 is localized to the plasma membrane and is responsible for basal glucose uptake; in no other cell type is GLUT1 a Golgi resident. To test the hypothesis that GLUT1 is targeted to Golgi during lactation, the amount and subcellular distribution of GLUT1 were examined in mouse mammary gland at different developmental stages. Methods including immunohistochemistry, immunofluorescence, subcellular fractionation, density gradient centrifugation, and Western blotting yielded consistent results. In virgins, GLUT1 expression was limited to plasma membrane of epithelial cells. In late pregnant mice, GLUT1 expression was increased with targeting primarily to basolateral plasma membrane but also with some intracellular signal. During lactation, GLUT expression was further increased, and targeting to Golgi, demonstrated by colocalization with the 110-kD coatomer-associated protein beta-COP, predominated. Removal of pups 18 d after delivery resulted in retargeting of GLUT1 from Golgi to plasma membrane and a decline in total cellular GLUT1 within 3 h. In mice undergoing natural weaning, GLUT1 expression declined. Changes in the amount and targeting of GLUT1 during mammary gland development are consistent with a key role for GLUT1 in supplying substrate for lactose synthesis and milk production.


Subject(s)
Golgi Apparatus/metabolism , Lactation , Mammary Glands, Animal/metabolism , Monosaccharide Transport Proteins/metabolism , Animals , Blotting, Western , Female , Glucose Transporter Type 1 , Immunohistochemistry , Mammary Glands, Animal/growth & development , Mammary Glands, Animal/physiology , Mice , Microscopy, Fluorescence/methods , Pregnancy , Subcellular Fractions/metabolism
9.
Am J Crit Care ; 8(3): 170-9, 1999 May.
Article in English | MEDLINE | ID: mdl-10228658

ABSTRACT

OBJECTIVE: To test an alternative flexible approach to traditional fixed intermediate and intensive care to minimize transfers of patients. METHODS: Patients admitted to a 28-bed nursing unit with intermediate care potential and a 12-bed intensive care unit at a 300-bed teaching community hospital were studied. The group included 524 patients with a discharge diagnosis code for mechanical ventilation. During eight 3-week cycles, 1073 transfers of patients were tabulated. A plan-do-study-act method was used to improve weaning from mechanical ventilation and reduce the number of inappropriate days in intensive care. Admissions and transfers to the 2 units for all patients during the eight 3-week cycles were compared over time. Length of stay and mortality were noted for all patients treated with conventional and noninvasive ventilation. RESULTS: Direct admissions to the flexible intermediate unit increased with no overall change in admissions to the intensive care unit. Fewer patients needed conventional ventilation, and more in both units were treated with noninvasive ventilation. The median number of transfers per patient treated with mechanical ventilation decreased from 1.94 to 1.20. Length of stay and mortality also decreased among such patients. Some cost savings were attributable to the decrease in the number of transfers. Transfers out of the hospital directly from the intensive care unit increased from 2.24% to 4.43%. CONCLUSIONS: In a community teaching hospital, flexible care policies decreased the number of in-hospital transfers of patients treated with mechanical ventilation.


Subject(s)
Critical Care/organization & administration , Patient Transfer , Critical Care/methods , Hospital Mortality , Hospitals, Community , Hospitals, Teaching , Humans , Length of Stay , Respiration, Artificial , United States
10.
Klin Monbl Augenheilkd ; 178(5): 390-1, 1981 May.
Article in German | MEDLINE | ID: mdl-7253531

ABSTRACT

The effect of Solcoseryl Eye Jelly (a protein-free extract from blood of young calves) was studied in 202 cases of corneal diseases of various etiology. It had an accelerating action on the reepithelization of the cornea after alkali burns, inflammations, injuries (foreign body and contact lenses and in keratoconjunctivitis sicca. The stability of the precorneal film was increased. The tendency toward symblepharon formation after alkali burns was considerably reduced.


Subject(s)
Actihaemyl/therapeutic use , Corneal Diseases/drug therapy , Tissue Extracts/therapeutic use , Administration, Topical , Corneal Injuries , Eye Burns/drug therapy , Humans , Keratitis/drug therapy , Keratoconjunctivitis/drug therapy
13.
Klin Monbl Augenheilkd ; 169(4): 496-9, 1976 Oct.
Article in German | MEDLINE | ID: mdl-994407

ABSTRACT

Tubular inclusions in the capillary endothelium were observed in three retinoblastomas. The structure of these inclusions is the same as that observed in the capillary endothelium of the dog's retina.


Subject(s)
Eye Neoplasms/ultrastructure , Retinoblastoma/ultrastructure , Animals , Dogs , Endoplasmic Reticulum , Endothelium/ultrastructure , Microscopy, Electron , Mitochondria
14.
Ophthalmologica ; 170(5): 434-45, 1975.
Article in English | MEDLINE | ID: mdl-1153166

ABSTRACT

The authors examined the effect of calcium dobesilate (Doxium ¿) on 85 subjects with diabetic retinopathy, occlusion of the central vein of the retina and other retinopathies of vascular origin. Capillary resistance measured on the skin and conjunctiva showed, as compared with 100 healthy subjects, a significant decrease. The efficacy of long-term treatment with Doxium was highly significant in restoring CR to normal. Visual acuity improved in 45.8% of simple DR cases, and became stabilized in 27.5% of cases with malignant DR. Hyperpermeability of retinal vessels decreased in 60% of simple DR cases. It is pointed out that glaucoma did not develop in cases of venous occlusion and the diagnostic value of capillary resistance measurement in diabetes. As a highly effective vasoprotective drug, Doxium¿ is the treatment of choice in all retinopathies of vascular etiology.


Subject(s)
Benzenesulfonates/therapeutic use , Calcium Dobesilate/therapeutic use , Diabetic Retinopathy/drug therapy , Adolescent , Adult , Calcium Dobesilate/pharmacology , Depression, Chemical , Female , Fluorescein Angiography , Fundus Oculi , Humans , Male , Middle Aged , Retinal Diseases/drug therapy , Retinal Vessels/drug effects , Vascular Resistance/drug effects , Visual Acuity
15.
Ophthalmologica ; 170(6): 534-42, 1975.
Article in German | MEDLINE | ID: mdl-1153170

ABSTRACT

In eyelid epitheloimata: basaliomata, spinaliomata and warts very numerous Langerhans granules were found in Langerhans cells


Subject(s)
Carcinoma, Basal Cell/pathology , Eyelid Neoplasms/pathology , Langerhans Cells/ultrastructure , Warts/pathology , Adult , Aged , Female , Humans , Male , Microscopy, Electron , Middle Aged
19.
Orv Hetil ; 109(4): 195-7, 1968 Jan 28.
Article in Hungarian | MEDLINE | ID: mdl-5678047
SELECTION OF CITATIONS
SEARCH DETAIL
...